PROLACTIN AS A VACCINE ADJUVANT - Patent 0952846

(19)

(11)

EP 0 952 846 A1

(12)

(43)	Date of publication:
	03.11.1999 Bulletin 1999/44

(21)	Application number: 95910999.0

(22)	Date of filing: 14.02.1995

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 39/ 39^{( . )}
A61P 31/ 04^{( . )}
A61P 37/ 04^{( . )}
C12P 21/ 02^{( . )}

A61K 38/ 24^{( . )}
A61K 48/ 00^{( . )}
A61P 31/ 12^{( . )}
C07K 14/ 575^{( . )}
A61K 39/ 00^{( . )}

(86)	International application number:
	PCT/US1995/001866

(87)	International publication number:
	WO 1995/021625 (17.08.1995 Gazette 1995/35)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

14.02.1994 US 19940196350

(71)	Applicant: GENZYME CORPORATION
	Cambridge, Massachusetts 02139-1562 (US)

(72)	Inventors:
	RICHARDS, Susan Framingham, MA 01701 (US) KAPLAN, Johanne Sherborn, MA 01770 (US) MOSCICKI, Richard Newton Center, MA 02159 (US)

(74)	Representative: Froud, Clive, et al
	Elkington and Fife Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR Sevenoaks, Kent TN13 1XR (GB)

(54)	PROLACTIN AS A VACCINE ADJUVANT